Mihaela Druta

Hematology | Oncology
12902 Usf Magnolia Dr
Tampa, FL 33612

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Evaluation of the Feasibility and Safety of Ifosfamide-Based Chemotherapy Regimens for Sarcomas in the Outpatient Setting.

Evaluation of the Feasibility and Safety of Ifosfamide-Based Chemotherapy Regimens for Sarcomas in the Outpatient Setting.

Journal: JCO oncology practice
Published: July 06, 2026

A Phase 1/2 study of ontorpacept (TTI-621) in combination with doxorubicin in patients with unresectable or metastatic high-grade leiomyosarcoma.

A Phase 1/2 study of ontorpacept (TTI-621) in combination with doxorubicin in patients with unresectable or metastatic high-grade leiomyosarcoma.

Journal: British journal of cancer
Published: January 14, 2026

Drug-eluting bead transarterial chemoembolization treatment of liver-dominant metastatic leiomyosarcoma.

Drug-eluting bead transarterial chemoembolization treatment of liver-dominant metastatic leiomyosarcoma.

Journal: Abdominal radiology (New York)
Published: September 03, 2025

Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma.

Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 21, 2025

Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcoma.

Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcoma.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 05, 2024

Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes.

Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes.

Journal: Nature communications
Published: May 07, 2024

Radioembolization of Primary Splenic Angiosarcoma Complicated by Delayed Gastric Hemorrhage.

Radioembolization of Primary Splenic Angiosarcoma Complicated by Delayed Gastric Hemorrhage.

Journal: Journal of vascular and interventional radiology : JVIR
Published: March 06, 2024

Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.

Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.

Journal: Lancet (London, England)
Published: December 21, 2023

Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study.

Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study.

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 17, 2023

Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial.

Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial.

Journal: Nature medicine
Published: March 31, 2023

Anti-PD-1 therapy in advanced sarcomas: is cutaneous primary site a stronger predictor of response than histologic subtype?

Anti-PD-1 therapy in advanced sarcomas: is cutaneous primary site a stronger predictor of response than histologic subtype?

Journal: Cancer immunology, immunotherapy : CII
Published: December 27, 2022

A Case of Hepatic Malignant Solitary Fibrous Tumor: A Case Report and Review of the Literature.

A Case of Hepatic Malignant Solitary Fibrous Tumor: A Case Report and Review of the Literature.

Journal: Case reports in pathology
Published: October 03, 2022
Showing 1-12 of 28

Last Updated: 09/26/2026